产品编号 | bsm-60714R |
英文名称 | PDCD2 Recombinant Rabbit mAb |
中文名称 | 凋亡相关蛋白2重组兔单抗 |
别 名 | PDCD2_HUMAN; PDCD 2; Programmed cell death 2; Programmed cell death protein 2; RP 8; RP8; Zinc finger MYND domain containing protein 7; Zinc finger MYND domain-containing protein 7; Zinc finger protein Rp 8; Zinc finger protein Rp-8; Zinc finger protein R |
研究领域 | 肿瘤 细胞生物 细胞凋亡 细胞周期蛋白 转录调节因子 |
抗体来源 | Rabbit |
克隆类型 | |
克 隆 号 | R5D3 |
交叉反应 | (predicted: Human, Mouse, Rat, ) |
产品应用 | WB=1:500-2000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理论分子量 | 39 kDa |
检测分子量 | |
细胞定位 | 细胞浆 细胞膜 |
性 状 | Liquid |
浓 度 | 1mg/ml |
免 疫 原 | KLH conjugated synthetic peptide derived from human PDCD2 |
亚 型 | IgG |
纯化方法 | affinity purified by Protein A |
缓 冲 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
保存条件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
产品介绍 |
This gene encodes a nuclear protein expressed in a variety of tissues. Expression of this gene has been shown to be repressed by B-cell CLL/lymphoma 6 (BCL6), a transcriptional repressor required for lymph node germinal center development, suggesting that BCL6 regulates apoptosis by its effects on this protein. Alternative splicing results in multiple transcript variants and pseudogenes have been identified on chromosomes 9 and 12. [provided by RefSeq, Dec 2010] Subcellular Location: Nucleus. Tissue Specificity: Ubiquitous. SWISS: Q16342 Gene ID: 5134 Database links:
Entrez Gene: 5134 Human Entrez Gene: 18567 Mouse SwissProt: Q16342 Human SwissProt: P46718 Mouse
|
产品图片 |
Blocking buffer: 5% NFDM/TBST
Primary Ab dilution: 1:2000
Primary Ab incubation condition: 2 hours at
room temperature
Secondary Ab: Goat Anti-Rabbit IgG H&L
(HRP)
Lysate: 1: 293T, 2: HeLa, 3: NIH/3T3, 4: BRL
Protein loading quantity: 20 μg
Exposure time: 60 s
Predicted MW: 39 kDa
Observed MW: 39 kDa
|
1、抗体溶解方法 | |
2、抗体修复方式 | |
3、常用试剂的配制 | |
4、免疫组化操作步骤 | |
5、免疫组化问题解答 | |
6、Western Blotting 操作步骤 | |
7、Western Blotting 问题解答 | |
8、关于肽链的设计 | |
9、多肽的溶解与保存 | |
10、酶标抗体效价测定程序 | |